Weight management and cardiovascular risk reduction: The role of Semaglutide 2.4mg
Description
In this Product Explainer, Dr. Robert Hungerford, GP with a special interest in ASCVD, heart failure and diabetes, explains the role of Semaglutide 2.4mg in weight management and cardiovascular risk reduction in secondary prevention (7 mins).
NEXT LIVE Webcast
:
Days
:
Hours
:
Minutes
Seconds
Prof Andrew Sindone
An Update on Heart Failure in Primary Care
Dr Gabby Mahoney
Allergen Introduction – Practical Tips for GPs
Prof Kim Delbaere
Falls Prevention – A Practical, Evidence-Based Update on What Really Works
Dr Stephanie Daly
The New Dementia Test and How they Fit Into the Assessment and Management of the Patient with Cognitive Concerns
Join us for the next free webcast for GPs and healthcare professionals
High quality lectures delivered by leading independent experts
